Online citations, reference lists, and bibliographies.

Conjunctivitis: A Systematic Review Of Diagnosis And Treatment.

Amir A. Azari, Neal P. Barney
Published 2013 · Medicine
Cite This
Download PDF
Analyze on Scholarcy
Share
IMPORTANCE Conjunctivitis is a common problem. OBJECTIVE To examine the diagnosis, management, and treatment of conjunctivitis, including various antibiotics and alternatives to antibiotic use in infectious conjunctivitis and use of antihistamines and mast cell stabilizers in allergic conjunctivitis. EVIDENCE REVIEW A search of the literature published through March 2013, using PubMed, the ISI Web of Knowledge database, and the Cochrane Library was performed. Eligible articles were selected after review of titles, abstracts, and references. FINDINGS Viral conjunctivitis is the most common overall cause of infectious conjunctivitis and usually does not require treatment; the signs and symptoms at presentation are variable. Bacterial conjunctivitis is the second most common cause of infectious conjunctivitis, with most uncomplicated cases resolving in 1 to 2 weeks. Mattering and adherence of the eyelids on waking, lack of itching, and absence of a history of conjunctivitis are the strongest factors associated with bacterial conjunctivitis. Topical antibiotics decrease the duration of bacterial conjunctivitis and allow earlier return to school or work. Conjunctivitis secondary to sexually transmitted diseases such as chlamydia and gonorrhea requires systemic treatment in addition to topical antibiotic therapy. Allergic conjunctivitis is encountered in up to 40% of the population, but only a small proportion of these individuals seek medical help; itching is the most consistent sign in allergic conjunctivitis, and treatment consists of topical antihistamines and mast cell inhibitors. CONCLUSIONS AND RELEVANCE The majority of cases in bacterial conjunctivitis are self-limiting and no treatment is necessary in uncomplicated cases. However, conjunctivitis caused by gonorrhea or chlamydia and conjunctivitis in contact lens wearers should be treated with antibiotics. Treatment for viral conjunctivitis is supportive. Treatment with antihistamines and mast cell stabilizers alleviates the symptoms of allergic conjunctivitis.
This paper references
10.1002/14651858.cd001211.pub2
Antibiotics versus placebo for acute bacterial conjunctivitis.
Aziz Sheikh (2006)
10.1001/archopht.1982.01030040253009
Laboratory studies in acute conjunctivitis.
Susan M. Stenson (1982)
10.3126/nepjoph.v3i2.5271
Ocular manifestations in herpes zoster ophthalmicus.
Lila Raj Puri (2011)
10.1016/j.clinthera.2010.12.004
Efficacy and tolerability of besifloxacin ophthalmic suspension 0.6% administered twice daily for 3 days in the treatment of bacterial conjunctivitis: a multicenter, randomized, double-masked, vehicle-controlled, parallel-group study in adults and children.
Bruce E Silverstein (2011)
10.1016/j.annemergmed.2011.04.006
Sexually transmitted diseases treatment guidelines, 2010.
Kimberly Workowski (2010)
10.1177/112067219900900403
Treatment of Acute Bacterial Conjunctivitis with Topical Lomefloxacin 0.3% Compared to Topical Ofloxacin 0.3%
Kf Tabbara (1999)
A DOUBLE-BLIND DOUBLE-DUMMY COMPARISON OF TOPICAL LOMEFLOXACIN 0.3% TWICE DAILY WITH TOPICAL GENTAMICIN 0.3% FOUR TIMES DAILY IN THE TREATMENT OF ACUT E BACTERIAL CONJUNCTIVITIS
Javier A. Montero (1998)
10.1111/j.1755-3768.1993.tb04983.x
Acute conjunctivitis. A comparison of fusidic acid viscous eye drops and chloramphenicol.
Ivar Hørven (1993)
10.3928/01913913-20081101-07
A multicenter comparison of polymyxin B sulfate/trimethoprim ophthalmic solution and moxifloxacin in the speed of clinical efficacy for the treatment of bacterial conjunctivitis.
David B. Granet (2008)
10.1016/S0149-2918(00)83044-1
Comparison of the clinical efficacy and comfort of olopatadine hydrochloride 0.1% ophthalmic solution and nedocromil sodium 2% ophthalmic solution in the human conjunctival allergen challenge model.
Salim I. Butrus (2000)
10.1016/S0002-9394(02)02094-9
Azithromycin vs doxycycline in the treatment of inclusion conjunctivitis.
Damir Katušić (2003)
10.1136/bmj.327.7418.789
Diagnostic impact of signs and symptoms in acute infectious conjunctivitis: systematic literature search
Remco P Rietveld (2003)
10.1136/bjo.84.9.968
Clinical and epidemiological features of acute follicular conjunctivitis with special reference to that caused by herpes simplex virus type 1
Eiichi Uchio (2000)
Evaluation of the clinical and microbiological efficacy of 0.3% ciprofloxacin drops and 0.3% tobramycin drops in the treatment of acute bacterial conjunctivitis
Alves MRKJ (1993)
10.1093/jac/23.2.261
Trimethoprim-polymyxin B sulphate ophthalmic ointment versus chloramphenicol ophthalmic ointment in the treatment of bacterial conjunctivitis--a review of four clinical studies. The Trimethoprim-Polymyxin B Sulphate Ophthalmic Ointment Study Group.
(1989)
10.1097/00003226-198706040-00011
Diagnosis and management of herpes simplex stromal keratitis.
Kirk R. Wilhelmus (1987)
10.1097/ACI.0b013e32834a9676
Epidemiology of allergic conjunctivitis.
Nelson A Rosario (2011)
10.1016/j.emc.2007.10.002
Diagnosis and management of the acute red eye.
Ahmed R. Mahmood (2008)
10.1177/000992289703600801
A Comparison of Ciprofloxacin and Tobramycin in Bacterial Conjunctivtis in Children
Robert D. Gross (1997)
10.1097/00003226-200201000-00010
Treatment of acute bacterial conjunctivitis with topical netilmicin.
Vincenzo Papa (2002)
10.1016/j.ophtha.2006.06.029
The RPS adeno detector for diagnosing adenoviral conjunctivitis.
Robert Sambursky (2006)
10.1136/bmj.329.7466.625-b
Predicting bacterial cause in infectious conjunctivitis: Three more questions for “conjunctivitis” may be important
A B Fierz (2004)
10.1038/eye.1987.77
Adult follicular conjunctivitis and neonatal ophthalmia in a Liverpool eye hospital, 1980–1984
Simon Peter Harding (1987)
10.1016/0035-9203(92)90328-A
Causes of conjunctivitis and keratoconjunctivitis in Karachi, Pakistan.
Ralph M. Woodland (1992)
10.1093/infdis/160.6.938
A large outbreak of epidemic keratoconjunctivitis: problems in controlling nosocomial spread.
David K. Warren (1989)
10.1097/00132980-200512000-00016
Allergic reaction to topical eyedrops.
Christophe Baudouin (2005)
10.1136/bjo.2006.103556
3-day treatment with azithromycin 1.5% eye drops versus 7-day treatment with tobramycin 0.3% for purulent bacterial conjunctivitis: multicentre, randomised and controlled trial in adults and children
Isabelle Cochereau (2007)
A comparison of eye problems in primary care and ophthalmology practices.
Tamlyn Shields (1991)
10.1159/000027430
Topical Lomefloxacin 0.3% Twice Daily versus Tobramycin 0.3% in Acute Bacterial Conjunctivitis: A Multicenter Double-Blind Phase III Study
Pier Enrico Gallenga (1999)
10.1097/INF.0b013e3181b99fa2
Efficacy and safety of azithromycin 1.5% eye drops for purulent bacterial conjunctivitis in pediatric patients.
Dominique Brémond-Gignac (2010)
Bacterial conjunctivitis.
John W. Epling (2010)
10.1007/BF02848694
Single dose of ketotifen fumarate .025% vs 2 weeks of cromolyn sodium 4% for allergic conjunctivitis
Jack V. Greiner (2002)
Topical antibiotics for acute bacterial conjunctivitis: Cochrane systematic review and meta-analysis update.
Aziz Sheikh (2005)
Chlamydial disease. In: Albert and Jakobiec's Principle and Practice of Ophthalmology
RK Avery (2008)
10.1097/ICU.0b013e3283477cb5
Adenovirus advances: new diagnostic and therapeutic options.
Herbert E. Kaufman (2011)
10.1111/j.1755-3768.2011.02272.x
Management of seasonal allergic conjunctivitis: guide to therapy.
Brett P. Bielory (2012)
Diagnosis andmanagement of dural carotid - cavernous sinus fistulas
NR Miller (2007)
10.2165/11585330-000000000-00000
Treatment of Viral Conjunctivitis with Antiviral Drugs
Chrysanthi L. Skevaki (2012)
10.1034/j.1600-0420.2003.00079.x
Comparative study of 0.1% olopatadine hydrochloride and 0.5% ketorolac tromethamine in the treatment of seasonal allergic conjunctivitis.
Volkan Yaylalı (2003)
10.1016/S1542-0124(12)70273-2
The ophthalmologic management of acute Stevens-Johnson syndrome.
Darren G. Gregory (2008)
Topical treatments for seasonal allergic conjunctivitis: systematic review and meta-analysis of efficacy and effectiveness.
Christopher G. Owen (2004)
American College of Cardiology / American Heart Association clinical practice guidelines , part I
RJ Gibbons (2003)
10.4135/9781412950558.n72
[Centers for Disease Control and Prevention (CDC)].
Pierre Wolkenstein (2000)
10.1016/j.clinthera.2005.04.011
A comparison of the clinical efficacy of pheniramine maleate/naphazoline hydrochloride ophthalmic solution and olopatadine hydrochloride ophthalmic solution in the conjunctival allergen challenge model.
Jack V. Greiner (2005)
10.1016/S0161-6420(89)32749-7
Epidemiology and diagnosis of acute conjunctivitis at an inner-city hospital.
Clyde Fitch (1989)
Diagnosis and management of dural carotid-cavernous sinus fistulas. Neurosurg Focus
NR Miller (2013)
Chlamydial disease
RK Avery (2008)
10.4269/ajtmh.2003.69.24
The global elimination of blinding trachoma: progress and promise.
Jacob A Kumaresan (2003)
10.1016/S0002-9394(14)70640-3
Possible consequences of shaking hands with your patients with epidemic keratoconjunctivitis.
Michel Azar (1996)
10.1016/S0008-4182(02)80114-4
Treatment of acute bacterial conjunctivitis: 1% fusidic acid viscous drops vs. 0.3% tobramycin drops.
William B. Jackson (2002)
10.1016/b978-1-4160-4919-7.50064-5
Disorders of the conjunctiva and limbus
Fred F. Ferri (2009)
10.3949/ccjm.75.7.507
Bacterial conjunctivitis: a review for internists.
Ahmad B. Tarabishy (2008)
10.3171/FOC-07/11/E13
Diagnosis and management of dural carotid-cavernous sinus fistulas.
N. R. Miller (2007)
10.1161/01.CIR.0000063682.20730.A5
American College of Cardiology/American Heart Association clinical practice guidelines: Part I: where do they come from?
Raymond J. Gibbons (2003)
10.1136/bjo.87.8.1004
A phase III, placebo controlled clinical trial of 0.5% levofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis
David Hwang (2003)
10.1016/S0161-6420(02)01894-8
A phase III clinical trial of 0.5% levofloxacin ophthalmic solution versus 0.3% ofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis.
Ivan R. Schwab (2003)
10.1111/j.1600-0420.1999.tb01174.x
Comparative evaluation of olopatadine ophthalmic solution (0.1%) versus ketorolac ophthalmic solution (0.5%) using the provocative antigen challenge model.
Jean Deschênes (1999)
10.1136/bmj.329.7466.625-d
Predicting bacterial cause in infectious conjunctivitis: Authors' reply
Remco P Rietveld (2004)
10.1136/sti.72.3.203
Epidemiology of genital chlamydial infections in patients with chlamydial conjunctivitis; a retrospective study.
E J Postema (1996)
10.1097/MAJ.0b013e3181637417
Cost effectiveness of a point-of-care test for adenoviral conjunctivitis.
Belinda L. Udeh (2008)
10.1038/sj.eye.6701465
External ocular infections due to methicillin-resistant Staphylococcus aureus (MRSA)
Vijay A Shanmuganathan (2005)
10.1016/j.clinthera.2009.03.010
Besifloxacin ophthalmic suspension 0.6% in patients with bacterial conjunctivitis: A multicenter, prospective, randomized, double-masked, vehicle-controlled, 5-day efficacy and safety study.
Paul M. Karpecki (2009)
Diagnosis and management of red eye in primary care.
Holly Cronau (2010)
10.2500/aap.2012.33.3525
Allergic conjunctivitis: the evolution of therapeutic options.
Leonard Bielory (2012)
10.1136/bjo.69.5.385
Prevalence of chlamydial eye infection in patients attending an eye clinic, a VD clinic, and in healthy persons.
R Rönnerstam (1985)
Tolerancia y eficacia de la tobramicina tópica vs cloranfenicol en el tratamiento de las conjunctivitis bacterianas
Valentín Huerva (1991)
10.1016/j.ajo.2008.01.019
Clinical cure of bacterial conjunctivitis with azithromycin 1%: vehicle-controlled, double-masked clinical trial.
Mark B. Abelson (2008)
10.1097/ICO.0b013e31823cbe6a
Practice patterns and opinions in the management of recurrent or chronic herpes zoster ophthalmicus.
Aileen Sy (2012)
10.1177/112067210801800602
Microbiologic Efficacy of 3-day Treatment with Azithromycin 1.5% Eyedrops for Purulent Bacterial Conjunctivitis
François Denis (2008)
10.1016/j.ajo.2007.03.032
Spectrum of eye disease caused by methicillin-resistant Staphylococcus aureus.
Julie Freidlin (2007)
10.1161/01.CIR.0000145143.19711.78
Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.
Jane W Newburger (2004)
Antibacterial effectiveness of ciprofloxacin 0.3% ophthalmic solution in the treatment of bacterial conjunctivitis.
Howard M. I. Leibowitz (1991)
10.1016/j.ophtha.2009.05.014
Efficacy and safety of besifloxacin ophthalmic suspension 0.6% compared with moxifloxacin ophthalmic solution 0.5% for treating bacterial conjunctivitis.
Marguerite B Mcdonald (2009)
10.1007/BF02854842
Efficacy and safety of ketorolac tromethamine 0.5% and levocabastine 0.05%: a multicenter comparison in patients with seasonal allergic conjunctivitis
Peter C. Donshik (2000)
[Comparative research of the efficacy of the gatifloxacin and levofloxacin for bacterial conjunctivitis in human eyes].
Lan Gong (2010)
10.1111/j.1600-0420.2007.01006.x
Acute bacterial conjunctivitis.
Gunnar Høvding (2008)
10.1185/03007990902837919
Phase III efficacy and safety study of besifloxacin ophthalmic suspension 0.6% in the treatment of bacterial conjunctivitis.
Michael E Tepedino (2009)
10.1185/03007990903038269
Acute conjunctivitis: truth and misconceptions
Terrence P. O'brien (2009)
10.1177/112067210901900101
Clinical and Microbiological Efficacy of Levofloxacin Administered three Times a Day for the Treatment of Bacterial Conjunctivitis
Jacek P Szaflik (2009)
10.1002/jmv.1890250306
Spread of acute hemorrhagic conjunctivitis due to enterovirus-70: effect of air temperature and relative humidity on virus survival on fomites.
Syed A Sattar (1988)
10.3928/01913913-20070301-03
Exclusion of students with conjunctivitis from school: policies of state departments of health.
Christina Ohnsman (2007)
10.1016/S0149-2918(03)80200-X
A placebo-controlled comparison of ketotifen fumarate and nedocromil sodium ophthalmic solutions for the prevention of ocular itching with the conjunctival allergen challenge model.
Jack V. Greiner (2003)
10.1056/NEJM200008033430507
The red eye.
Howard M. I. Leibowitz (2000)
[Clinical investigation of 0.3% levofloxacin eyedrops on the treatment of cases with acute bacterial conjunctivitis and bacterial keratitis].
Ming-Chang Zhang (2000)
10.1097/00006454-198809000-00005
Comparison of three topical antimicrobials for acute bacterial conjunctivitis.
Jacob A. Lohr (1988)
10.1016/0002-9394(57)90152-6
Clinical trial of erythromycin ophthalmic ointment.
John W. Hallett (1957)
10.1186/1471-2415-9-13
Estimate of the direct and indirect annual cost of bacterial conjunctivitis in the United States
Andrew F Smith (2009)



This paper is referenced by
10.1177/1040638716642268
Diagnostic investigation of new disease syndromes in farmed Australian saltwater crocodiles (Crocodylus porosus) reveals associations with herpesviral infection
Catherine M Shilton (2016)
10.1089/JOP.2017.0056
Efficacy and Safety of 0.6% Pazufloxacin Ophthalmic Solution Versus Moxifloxacin 0.5% and Gatifloxacin 0.5% in Subjects with Bacterial Conjunctivitis: A Randomized Clinical Trial.
Baiza-DuránLeopoldo (2018)
10.2147/OPTH.S236571
A Review of the Differential Diagnosis of Acute Infectious Conjunctivitis: Implications for Treatment and Management
Elizabeth Yeu (2020)
10.1007/978-3-319-72063-0
Staphylococcus aureus
Д. Іванова (2017)
10.1089/jop.2014.0040
Gatifloxacin 0.5% administered twice daily for the treatment of acute bacterial conjunctivitis in patients one year of age or older.
Warren H Heller (2014)
Conjunctivitis in Children: when to Prescribe an Antibiotic
Sahbaa Fehr (2018)
10.1186/s12955-019-1223-9
Content validity of a novel patient-reported and observer-reported outcomes assessment to evaluate ocular symptoms associated with infectious conjunctivitis in both adult and pediatric populations
Sujata P. Sarda (2019)
10.2147/OPTH.S181997
Treatment-Resistant Bacterial Keratitis: Challenges and Solutions
Sait Eğrilmez (2020)
10.1093/cid/ciaa202
Unraveling the Impact of Pneumococcal Conjugate Vaccines on Bacterial Conjunctivitis in Children.
Leigh M Howard (2020)
10.1016/j.aller.2017.05.005
Tear osteopontin level and its relationship with local Th1/Th2/Th17/Treg cytokines in children with allergic conjunctivitis.
Aihua Yan (2018)
10.1186/s12879-019-4232-8
An outbreak of epidemic keratoconjunctivitis caused by human adenovirus type 8 in primary school, southwest China
Duo Li (2019)
10.5812/jjm.92549
Transmission Rates of Chlamydia trachomatis and Neisseria gonorrhoeae Infections from Pregnant Women to Newborns, Tehran, Iran
Alireza Esteghamati (2020)
10.5772/INTECHOPEN.76039
Chitosan: A Good Candidate for Sustained Release Ocular Drug Delivery Systems
Lăcrămioara Popa (2018)
10.14260/jemds/2014/3746
A PROSPECTIVE OBSERVATIONAL STUDY OF THE COURSE OF CLINICAL INFECTIVE CONJUNCTIVITIS & ANALYSIS OF THE SEQUEL OF ITS CORNEAL INVOLVEMENT
Manoj Vasudevan (2014)
10.4102/safp.v60i6.4933
A "site" for sore eyes
George L. Muntingh (2018)
10.1007/978-981-13-9871-1_3
Emergence and Spread of Multidrug Resistance in Ocular Bacterial Pathogens: A Current Update
Sarim Ahmad (2019)
10.1186/s12886-015-0078-z
Bacterial isolates and their antimicrobial susceptibility pattern among patients with external ocular infections at Borumeda hospital, Northeast Ethiopia
Birtukan Shiferaw (2015)
10.1007/s11427-016-5060-3
Etiological characteristics of chlamydia trachoma conjunctivitis of Primary Boarding School students in the Qinghai Tibetan area
Mei Jung Wang (2016)
10.1016/j.ajo.2020.03.018
A Prospective, Randomized Trial of Povidone-Iodine 0.6% and Dexamethasone 0.1% Ophthalmic Suspension for Acute Bacterial Conjunctivitis.
Christopher N. Ta (2020)
10.2147/OPTH.S202362
The epidemiology and treatment of conjunctivitis at Urgent Care Centres in Israel
Ariela Gordon-Shaag (2019)
10.1371/journal.pone.0205814
Antibiotic resistance among bacterial conjunctival pathogens collected in the Antibiotic Resistance Monitoring in Ocular Microorganisms (ARMOR) surveillance study
Penny A. Asbell (2018)
10.1016/j.pedhc.2016.02.001
Clinical Evaluation of Red Eyes in Pediatric Patients.
Casey J. Beal (2016)
10.1038/srep23858
Ambient air pollution, weather changes, and outpatient visits for allergic conjunctivitis: A retrospective registry study
Jiaxu Hong (2016)
10.15242/heaig.er0917215
A Study on the Etiologic Agents of Bacterial Eye Infections in Khartoum State
Nuha M. Elhage (2018)
10.1007/s10792-017-0678-0
An evidence-based medicine audit of the ophthalmic emergency services unit of King Abdulaziz University Hospital (KAUH)
Adel H. Alsuhaibani (2017)
Bacteriology and Antimicrobial Susceptibility Patterns of Childhood Acute Bacterial Conjunctivitis in Western Greece
Maria-Zoi Oikonomakou (2019)
10.1097/ICU.0000000000000485
Adenoviral keratitis: a review of the epidemiology, pathophysiology, clinical features, diagnosis, and management
Amro A Omari (2018)
10.9734/JAMCS/2019/V31I330113
Stochastic Optimal Control Model of Haemorrhagic Conjunctivitis Disease
Sacrifice Nana-Kyere (2019)
10.1097/ICO.0000000000000562
Phase 3 Randomized Double-Masked Study of Efficacy and Safety of Once-Daily 0.77% Olopatadine Hydrochloride Ophthalmic Solution in Subjects With Allergic Conjunctivitis Using the Conjunctival Allergen Challenge Model.
Eugene B. McLaurin (2015)
10.3390/pathogens7010009
The Pathogenesis of Staphylococcus aureus Eye Infections
Richard J O'Callaghan (2018)
10.1016/j.amjmed.2015.06.026
Bedside Diagnosis of the 'Red Eye': A Systematic Review.
Sirisha Narayana (2015)
10.2147/OPTH.S191275
A randomized controlled trial of povidone-iodine/dexamethasone ophthalmic suspension for acute viral conjunctivitis
Jay S. Pepose (2019)
See more
Semantic Scholar Logo Some data provided by SemanticScholar